Indika Gawarammana

Indika Gawarammana

Auto-generated profile, based on publicly available information

Indika Gawarammana

South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2004 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
IGIndika Bandara Gawarammana
Indika Bandara Gawarammana
SKS Abeysingha M Kularatne
S Abeysingha M Kularatne
RKRanjith P V Kumarasiri
Ranjith P V Kumarasiri
NSNimal Senanayake
Nimal Senanayake
WDWasantha P Dissanayake
Wasantha P Dissanayake
HAH Ariyasena
H Ariyasena
Objective: To investigate the efficacy of continuous infusion of hydrocortisone with or without chlorpheniramine bolus against early adverse reactions to polyspecific antivenom. Design and setting: P...

3 November 2017 in Clinical Toxicology
Verified
Journal Article
Closed access
IGIndika Gawarammana
Indika Gawarammana
NBNicholas A. Buckley
Nicholas A. Buckley
FMFahim Mohamed
Fahim Mohamed
KNKamal Naser
Kamal Naser
KJK. Jeganathan
K. Jeganathan
ADAndrew H. Dawson
Andrew H. Dawson
Context: Intentional self-poisoning with the herbicide paraquat has a very high case-fatality and is a major problem in rural Asia and Pacific. Objectives: We aimed to determine whether the addition of immunosuppression to supportive care offers benefit in resource poor Asian district hospitals. Materials and methods: We performed a randomised placebo-controlled trial comparing immunosuppression (intravenous cyclophosphamide up to 1 g/day for two days and methylprednisolone 1 g/day for three days, and then oral dexamethasone 8 mg three-times-a-day for 14 days) with saline and placebo tablets, in addition to standard care, in patients with acute paraquat self-poisoning admitted to six Sri Lankan hospitals between 1st March 2007 and 15th November 2010. The primary outcome was in-hospital mortality. Results: 299 patients were randomised to receive immunosuppression (147) or saline/placebo (152). There was no significant difference in in-hospital mortality rates between the groups (immunosuppression 78 [53%] vs. placebo 94 [62%] (Chi squared test 2.4, p = .12). There was no difference in mortality at three months between the immunosuppression (101/147 [69%]) and placebo groups (108/152 [71%]); (mortality reduction 2%, 95% CI: −8 to +12%). A Cox model did not support benefit from high-dose immunosuppression but suggested potential benefit from the subsequent two weeks of dexamethasone. Conclusions: We found no evidence that high dose immunosuppression improves survival in paraquat-poisoned patients. The continuing high mortality means further research on the use of dexamethasone and other potential treatments is urgently needed.

8 November 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CEChathurangi Edussuriya
Chathurangi Edussuriya
SDSampath Deegalla
Sampath Deegalla
IGIndika Gawarammana
Indika Gawarammana
Dengue fever is a systemic viral infection of epidemic proportions in tropical countries. The incidence of dengue fever is ever increasing and has doubled over the last few decades. Estimated 50million new cases are detected each year and close to 10000 deaths occur each year. Epidemics are unpredictable and unprecedented. When epidemics occur, health services are over whelmed leading to overcrowding of hospitals. At present there is no evidence that dengue epidemics can be predicted. Since the breeding of the dengue mosquito is directly influenced by environmental factors, it is plausible that epidemics could be predicted using weather data. We hypothesized that there is a mathematical relationship between incidence of dengue fever and environmental factors and if such relationship exists, new cases of dengue fever in the succeeding months can be predicted using weather data of the current month. We developed a mathematical model using machine learning technique. We used Island wide dengue epidemiology data, weather data and population density in developing the model. We used incidence of dengue fever, average rain fall, humidity, wind speed, temperature and population density of each district in the model. We found that the model is able to predict the incidence of dengue fever of a given month in a given district with precision (RMSE between 18- 35.3). Further, using weather data of a given month, the number of cases of dengue in succeeding months too can be predicted with precision (RMSE 10.4—30). Health authorities can use existing weather data in predicting epidemics in the immediate future and therefore measures to prevent new cases can be taken and more importantly the authorities can prepare local authorities for outbreaks.

2 June 2016 in Clinical Toxicology
Verified
Journal Article
Open access
TLThomas Lamb
Thomas Lamb
LSLiza R. Selvarajah
Liza R. Selvarajah
FMFahim Mohamed
Fahim Mohamed
SJShaluka Jayamanne
Shaluka Jayamanne
IGIndika Gawarammana
Indika Gawarammana
MEMichael Eddleston
Michael Eddleston
Background: Highly hazardous organophosphorus (OP) insecticides are responsible for most pesticide poisoning deaths. As they are removed from agricultural practice, they are often replaced by carbamate insecticides of perceived lower toxicity. However, relatively little is known about poisoning with these insecticides. Methods: We prospectively studied 1288 patients self-poisoned with carbamate insecticides admitted to six Sri Lankan hospitals. Clinical outcomes were recorded for each patient and plasma carbamate concentration measured in a sample to confirm the carbamate ingested. Findings: Patients had ingested 3% carbofuran powder (719), carbosulfan EC25 liquid (25% w/v, 389), or fenobucarb EC50 liquid (50% w/v, 127) formulations, carbamate insecticides of WHO Toxicity Classes Ib, II, and II, respectively. Intubation and ventilation was required for 183 (14.2%) patients while 71 (5.5%) died. Compared with carbofuran, poisoning with carbosulfan or fenobucarb was associated with significantly higher risk of death [carbofuran 2.2%; carbosulfan 11.1%, OR 5.5 (95% CI 3.0–9.8); fenobucarb 6.3%, OR 3.0 (1.2–7.1)] and intubation [carbofuran 6.1%; carbosulfan 27.0%, OR 5.7 (3.9–8.3); fenobucarb 18.9%, OR 3.6 (2.1–6.1)]. The clinical presentation and cause of death did not differ markedly between carbamates. Median time to death was similar: carbofuran 42.3 h (IQR 5.5–67.3), carbosulfan 21.3 h (11.5–71.3), and fenobucarb 25.3 h (17.3–72.1) (p = 0.99); no patients showed delayed onset of toxicity akin to the intermediate syndrome seen after OP insecticide poisoning. For survivors, median duration of intubation was 67.8 h (IQR 27.5–118.8) with no difference in duration between carbamates. Reduced GCS at presentation was associated with worse outcome although some patients with carbosulfan died after presentation with normal GCS. Conclusions: We did not find carbamate insecticide self-poisoning to vary markedly according to the carbamate ingested although the case fatality varied according to the concentration and formulation of the insecticide. Carbamate poisoning did not appear to be much less toxic than poisoning with some liquid OP insecticide formulations, e.g., chlorpyrifos EC40, that we have previously noted in these same hospitals (Lancet 2005, 366:1452–1459; QJM 2006, 99:513–522). Replacement of WHO Class II Toxicity OP insecticides in agriculture with high-strength liquid carbamate formulations may not substantially reduce case fatality after pesticide poisoning and, therefore, global suicide rates.

18 February 2020 in Clinical Toxicology
Verified
Journal Article
Closed access
EWEranga S. Wijewickrama
Eranga S. Wijewickrama
LGLalindra V. Gooneratne
Lalindra V. Gooneratne
AGAriaranee Gnanathasan
Ariaranee Gnanathasan
IGIndika Gawarammana
Indika Gawarammana
MGMangala Gunatilake
Mangala Gunatilake
Geoffrey IsbisterGeoffrey Isbister
Geoffrey Isbister
Context: Thrombotic microangiopathy (TMA) resulting in acute kidney injury (AKI) is an important complication of venomous snakebites. We aimed to describe TMA secondary to Russell’s viper (Daboia russelli) and hump-nosed viper (Hypnale spp.) bites and assess the effect of different treatments. Materials and methods: We undertook a prospective observational study of patients with AKI secondary to snakebite over a two-year period. Data recorded included: demographic details, clinical and laboratory features, treatment, complications and outcomes, until hospital discharge and at three months post-discharge. TMA was defined as the development of microangiopathic hemolytic anemia and thrombocytopenia along with AKI. Treatment with therapeutic plasma exchange (TPE; also known as plasmapheresis) and/or fresh frozen plasma (FFP) was determined by the treating clinician. Antivenom was given to all patients with evidence of systemic envenoming following Russell’s viper bites. Results: Fifty-nine patients were included in the analysis. Thirty-three (56%) were males and median age was 56 years. Forty-five (76%) developed TMA while a further 11 and two developed isolated thrombocytopenia and microangiopathic hemolytic anemia, respectively. Presence of TMA was associated with increased dialysis requirements (5 vs. 3) and longer hospital stay (18 vs. 12 days). Of the patients with TMA, nine received TPE with or without FFP infusions. The use of TPE was not associated with improved outcomes in patients with TMA based on requirement for blood transfusion, recovery of thrombocytopenia, requirement of dialysis and duration of hospital stay. Patients who did not receive TPE had better renal function at three months compared to patients who received this treatment. Conclusion: Presence of TMA in patients with Daboia and Hypnale bites was associated with a more prolonged course of AKI. Patients with TMA who were treated with TPE did not have improved early or late outcomes compared to patients who were not treated with TPE.

1 September 2020 in Clinical Toxicology
Verified
Journal Article
Closed access
EWEranga S. Wijewickrama
Eranga S. Wijewickrama
LGLalindra V. Gooneratne
Lalindra V. Gooneratne
AGAriaranee Gnanathasan
Ariaranee Gnanathasan
IGIndika Gawarammana
Indika Gawarammana
MGMangala Gunatilake
Mangala Gunatilake
Geoffrey IsbisterGeoffrey Isbister
Geoffrey Isbister
Acute kidney injury (AKI) is the most serious clinical manifestation of the Sri Lankan hump-nosed pit viper (Hypnale spp.) bites. Thrombotic microangiopathy (TMA) is increasingly recognized in asso...